Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Anai

Showing results (51-60 of 175) with videos related to

Pageof 18
Sort By:
Research and Reports in Urology|March 11, 2021
Effect of Prolonged Duration of Transrectal Ultrasound-Guided Biopsy of the Prostate and Pre-Procedure Anxiety on Pain in Patients without AnesthesiaYasushi Nakai, Nobumichi Tanaka, Toshihiko Matsubara, et al.
Oncology|June 7, 2018
Clinical Features and Risk Factors of Skeletal-Related Events in Genitourinary Cancer Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial CarcinomaTakuya Owari, Makito Miyake, Yasushi Nakai, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 13, 2020
Coverage of the external prostatic region by the hybrid method compared with the conventional method of prostate low-dose-rate brachytherapy: A randomized controlled studyNobumichi Tanaka, Isao Asakawa, Yasushi Nakai, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 4, 2009
1-tert-butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a selective tyrosine kinase inhibitor of fibroblast growth factor receptor-3 (FGFR3), inhibits cell proliferation of bladder cancer carrying the FGFR3 gene mutation along with up-regulation of p27/Kip1 and G1/G0 arrestMakito Miyake, Masazumi Ishii, Naoki Koyama, et al.
BMC Cancer|August 27, 2017
Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancerNobumichi Tanaka, Isao Asakawa, Yasushi Nakai, et al.
Oncology Reports|November 15, 2016
Potential biomarkers for the therapeutic efficacy of sorafenib, sunitinib and everolimusYasushi Nakai, Makito Miyake, Yosuke Morizawa, et al.
Lasers in Medical Science|May 5, 2018
Spectrophotometric photodynamic diagnosis of prostate cancer cells excreted in voided urine using 5-aminolevulinic acidYasushi Nakai, Makito Miyake, Satoshi Anai, et al.
IJU Case Reports|August 4, 2020
Amrubicin is effective against small cell carcinoma of the prostate as a second-line chemotherapeutic agent: A case reportFumisato Maesaka, Yasushi Nakai, Mitsuru Tomizawa, et al.
Urologic Oncology|July 7, 2009
Dual targeting of Bcl-2 and VEGF: a potential strategy to improve therapy for prostate cancerSatoshi Anai, Noboru Sakamoto, Yoshihisa Sakai, et al.
Surgical Neurology International|April 17, 2024
Usefulness of non-slip element percutaneous transluminal angioplasty scoring balloons in treating severe calcified lesions of the carotid artery for carotid artery stenting: A case reportYukinori Takase, Tatsuya Tanaka, Satoshi Anai, et al.
Pageof 18

Showing results (51-60 of 175) with videos related to

Sort By:
Pageof 18
Research and Reports in Urology|March 11, 2021
Effect of Prolonged Duration of Transrectal Ultrasound-Guided Biopsy of the Prostate and Pre-Procedure Anxiety on Pain in Patients without AnesthesiaYasushi Nakai, Nobumichi Tanaka, Toshihiko Matsubara, et al.
Oncology|June 7, 2018
Clinical Features and Risk Factors of Skeletal-Related Events in Genitourinary Cancer Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial CarcinomaTakuya Owari, Makito Miyake, Yasushi Nakai, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 13, 2020
Coverage of the external prostatic region by the hybrid method compared with the conventional method of prostate low-dose-rate brachytherapy: A randomized controlled studyNobumichi Tanaka, Isao Asakawa, Yasushi Nakai, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 4, 2009
1-tert-butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a selective tyrosine kinase inhibitor of fibroblast growth factor receptor-3 (FGFR3), inhibits cell proliferation of bladder cancer carrying the FGFR3 gene mutation along with up-regulation of p27/Kip1 and G1/G0 arrestMakito Miyake, Masazumi Ishii, Naoki Koyama, et al.
BMC Cancer|August 27, 2017
Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancerNobumichi Tanaka, Isao Asakawa, Yasushi Nakai, et al.
Oncology Reports|November 15, 2016
Potential biomarkers for the therapeutic efficacy of sorafenib, sunitinib and everolimusYasushi Nakai, Makito Miyake, Yosuke Morizawa, et al.
Lasers in Medical Science|May 5, 2018
Spectrophotometric photodynamic diagnosis of prostate cancer cells excreted in voided urine using 5-aminolevulinic acidYasushi Nakai, Makito Miyake, Satoshi Anai, et al.
IJU Case Reports|August 4, 2020
Amrubicin is effective against small cell carcinoma of the prostate as a second-line chemotherapeutic agent: A case reportFumisato Maesaka, Yasushi Nakai, Mitsuru Tomizawa, et al.
Urologic Oncology|July 7, 2009
Dual targeting of Bcl-2 and VEGF: a potential strategy to improve therapy for prostate cancerSatoshi Anai, Noboru Sakamoto, Yoshihisa Sakai, et al.
Surgical Neurology International|April 17, 2024
Usefulness of non-slip element percutaneous transluminal angioplasty scoring balloons in treating severe calcified lesions of the carotid artery for carotid artery stenting: A case reportYukinori Takase, Tatsuya Tanaka, Satoshi Anai, et al.
Pageof 18